Author Question: The patient who experiences nausea produces less stomach acid. The nurse recognizes this as having ... (Read 21 times)

cmoore54 · **on:** Jul 23, 2018

The patient who experiences nausea produces less stomach acid. The nurse recognizes this as having what effect?

A) Increases the feeling of nausea
B) Protects the lining of the upper GI tract
C) Stimulates the parasympathetic nervous system
D) Directs fluid to mucus production in the small bowel

Question 2

The nurse is caring for a female patient, aged 62, who has been admitted for treatment of metastatic melanoma. What agent would the nurse anticipate the physician is likely to order?

A) Aldesleukin
B) Interferon alfa 2b
C) Cyclosporine
D) Ipilimumab

frankwu0507 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

B
Feedback:
There is a large increase in the production of mucus in the upper GI tract, which is accompanied by a decrease in gastric acid production. This action protects the lining of the GI tract from potential damage by the acidic stomach contents when vomiting occurs. It does not increase the feeling of nausea, stimulate the parasympathetic nervous system, nor does it direct fluid to mucus production.

Answer to Question 2

D
Feedback:
Ipilimumab is a human cytotoxic T-cell antigen-4 blocking antibody. By blocking this site, T cells are activated and proliferate at a faster rate. It is used to treat patients with unresectable or metastatic melanoma. Aldesleukin is an interleukin, used for metastatic renal cell carcinoma in adults; a treatment of metastatic melanomas. Interferon alfa 2b is indicated for hairy cell leukemia, melanoma, AIDS-related Kaposi's sarcoma, chronic hepatitis B and C infections, intralesional treatment of condyloma acuminatum in patients 18 years of age or older. Cyclosporine is a T and B cell suppressor and is indicated for prophylaxis for organ rejection in kidney, liver, and heart transplants (used with corticosteroids); treatment of chronic rejection in patients previously treated with other immunosuppressants; treatment of rheumatoid arthritis; and recalcitrant psoriasis.